contravir.com
About ContraVir | ContraVir Pharmaceuticals
http://contravir.com/about-us
ContraVir Reports Positive Data from Phase 1b Study of CMX157; Head-to-Head Phase 2 Study vs. Viread Ongoing. Press enter to begin your search. Pipeline of Drug Candidates. ContraVir Pharmaceuticals has two mid-to-late stage clinical assets and actively seeks to expand its pipeline of targeted antiviral therapies. Explore our Pipeline. Having demonstrated favorable safety and efficacy in Phase 1 trials, ContraVir is developing CMX157 for Hepatitis B in Phase 2 clinical studies. Shingles and Shingles Pain.
contravir.com
FV-100 Overview | ContraVir Pharmaceuticals
http://contravir.com/fv-100
ContraVir Reports Positive Data from Phase 1b Study of CMX157; Head-to-Head Phase 2 Study vs. Viread Ongoing. Press enter to begin your search. We are currently conducting a pivotal Phase 3 trial that will compare FV-100 to valacyclovir (Valtrex ) with shingles pain reduction as a primary endpoint. Examples of Shingles Lesions. Shingles and Shingles Pain. The pain associated with an episode of shingles is attributed to both the damage caused to the affected nerves by the replication of varicella zoster v...